Loading organizations...
Rapafusyn Pharmaceuticals has raised $72.0M across 2 funding rounds.
Rapafusyn Pharmaceuticals has raised $72.0M in total across 2 funding rounds.
Rapafusyn Pharmaceuticals has raised $72.0M across 2 funding rounds. Most recently, it raised $44.0M Series A in September 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 8, 2025 | $44M Series A | — | Karen LIU, Jian LI, Haolin Sung, WEN Chen | Announced |
| Jun 24, 2024 | $28M Series A | Karen LIU, Proxima Ventures | Zhihua YU | Announced |
Rapafusyn Pharmaceuticals has raised $72.0M in total across 2 funding rounds.
Rapafusyn Pharmaceuticals's investors include Karen Liu, Jian Li, Haolin Sung, Wen Chen, Proxima Ventures, Zhihua Yu.
